À PROPOS DE CE PODCAST 🔗
EHA 2015
Durée audio moyenne:
7 minutes
Anglais
États-Unis
29 épisodes
depuis 6 août 2015
episodic
DERNIER ÉPISODE 🔗
Prof Anton Hagenbeek (Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands) talks to ecancertv at EHA 2015 about immunoconjugates, the latest targeted treatments in Hodgkin's lymphoma. He also suggests that patients with Hodgkin's disease partake in clinical trials.
ecan…
RECHERCHER LES ÉPISODES PASSÉS
Rechercher les épisodes précédents de EHA 2015.
ÉPISODES PRÉCÉDENTS 🔗
Dr Hoffmann (Ludwig Maximilian University, Munich, Germany) talks to ecancertv at EHA 2015 about a web-based registry to record all newly-diagnosed chronic myeloid leukaemia (CML) patients in 20 European countries or pre-specified regions covering overall 92.5 million inhabitants.
The researchers …
At a press conference at EHA 2015, Dr Mesa (Mayo Clinic Cancer Center, Scottsdale, USA) presented new data from the Phase 3 PERSIST-1 study which showed that pacritinib is more effective than the best available therapy (BAT) at improving disease symptoms and quality of life (QoL) for patients with …
Dr Olga Guryanova (Memorial Sloan Kettering Cancer Center, New York, USA) presents, at a press conference at EHA 2015, the findings of her work looking at the role of mutant DNMT3A in acute myeloid leukaemia (AML) pathogenesis and chemoresistance.
Dr Meletios Dimopoulos (National and Kapodistrian University of Athens, Athens, Greece) talks to ecancertv at EHA 2015 about the results of ELOQUENT-2, which evaluated elotuzumab in combination with lenalidomide and dexamethasone and is the first Phase III study to demonstrate the benefit of direct…
Dr Ehninger (University Hospital Dresden, Dresden, Germany) presents on the results of a phase II randomised study on the safety and efficacy of sorafenib in leukaemia at a press conference at EHA 2015.
Dr Roberts presents the promising results from an early phase trial combining the anti-bcl-2 drug venetoclax with rituximab to eliminate chronic lymphocytic leukaemia (CLL) at a press conference at EHA 2015.
Prof Anton Hagenbeek (University Medical Center Utrecht, Utrecht, Netherlands) talks to ecancertv at EHA 2015 about the results of Dr Andrew Roberts' early phase Ib trial which looked at combining the anti-bcl-2 drug venetoclax with rituximab to eliminate chronic lymphocytic leukaemia (CLL).
ecanc…
Prof Diehl ( Winner of the Jean Bernard Lifetime Achievement Award) talks to ecancertv at EHA 2015 about his amazing work in the field of Hodgkin's lymphoma and the evolution of research and treatment strategies over time.
ecancer's filming at EHA has been kindly supported by Amgen through the ECM…
Prof Max Topp ( Würzburg University Hospital, Würzburg, Germany) talks to ecancertv at EHA 2015 about his research which showed that acute lymphoblastic leukaemia (ALL) patients with low disease burden had lower responses to blinatumomab. Those with higher disease burden could be candidates for hig…
Avertissement: Le podcast et les illustrations intégrés sur cette page proviennent de ecancer, qui est la propriété de son propriétaire et n'est ni affilié ni approuvé par Listen Notes, Inc.
MOTEUR DE RECHERCHE DE PODCASTS
Vous pouvez utiliser notre site Web pour rechercher des podcasts3,828,673et des épisodes196,489,583par personnes, lieux ou sujets.
Investir dans le savoir offre le meilleur rendement, c'est pourquoi j'écoute des podcasts.
‐ Benjamin "Llamacorn" Franklin
RECHERCHER LES ÉPISODES PASSÉS
Rechercher les épisodes précédents de EHA 2015.
DEMANDER CE PODCAST
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post petites annonces for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
interview de podcasteur...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
notre compte officiel sur X (anciennement Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
MODIFIER
Merci de nous avoir aidé à tenir la base de données de podcasts à jour.
